Effektivnoe reshenie problemy antigipertenzivnoy terapii u patsienta s khronicheskoy ishemiey mozga
- Authors: Shishkova V.N1
-
Affiliations:
- Issue: No 18 (2013)
- Pages: 97-101
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/282644
- ID: 282644
Cite item
Open Access
Access granted
Abstract
Chronic cerebral ischemia is slow-progressive gradual decline or change the normal activity of the brain, which occurs as a result of diffuse and/or small-focal brain tissue damage in a settings of long-term lack of blood supply. Antihypertensive treatment at any stage of the treatment of hypertension can significantly affect the health of the patient's brain.
Full Text
References
- Дамулин И.В., Парфенов В.А., Скоромец А.А., Яхно Н.Н. Нарушения кровообращения в головном и спинном мозге. В кн.: Болезни нервной системы. Руководство для врачей / Под ред. Н.Н. Яхно. М., Т. 1. 2005.
- Фейгин В., Виберс Д., Браун Р. Инсульт: Клиническое руководство. М., СПб., 2005.
- Болезни нервной системы. Руководство для врачей/ Под ред. Н.Н. Яхно, Д.Р. Штульмана. М., 2004, Т. 1. С. 231-02.
- Скворцова В.И., Чазова Е.И., Стаховская Л.В. Вторичная профилактика инсульта. М., 2002.
- Старчина Ю.А. Ранняя диагностика и лечение когнитивных расстройств у пациентов с артериальной гипертензией. Дисс. канд. мед. наук. М., 2006.
- Harrington F, Saxby BK, McKeith IG, et al. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000;36:1079.
- Singh-Manoux, Marmot M. High blood pressure was associated with cognitive function in middle-age in the Whitehall II study. J Clin Epidemiol 2005;58(12):1308-15.
- Tatemichi TK, Desmond DW, Mayeux R, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992;42:1185-93.
- Диагностика и лечение артериальной гипертонии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов// Кардиоваскулярная терапия и профилактика 2010. Т. 7. № 6. Прил. 2.
- Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-51.
- PROGRESS collaborative Group. randomised trial of a perindoprilbased blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
- Trenkwalder P. The Study on COgnition and Prognosis in the Elderly (SCOPE) - recent analyses. J Hypertens 2006;24(Suppl. 1): 107-14. (3):19-21.
- Kehoe PG, Wilcock GK. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? Lancet Neurol 2007;6:373-78.
- Launer LJ, Petrovitch H, Ross GW, et al. AD brain pathology: vascular origins? Results from the HAAS autopsy study. Neurobiol 2008: 1587-90.
- Li NC, Lee A, Whitmer RA, et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 340, B5465 2010.
- Davies NM, et al. Associations of AntiHypertensive Treatments with Alzheimer's Disease, Vascular Dementia, and Other Dementhias. J Alzheimers Dis 2011; 26:699-708.
- Aronov WS, Fleg JL, Pepine CJ, et al. ACCF/ AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventing Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens 2011; 5:259-352.
Supplementary files
